3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Conditions
Leukemia, Myeloid, Acute
1540
Leukemia
1389
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1282
Leukemia, Lymphocytic, Chronic, B-Cell
1090
Myelodysplastic Syndromes
722
Lymphoma
658
Lymphoma, Non-Hodgkin
627
Hematologic Neoplasms
556
Lymphoma, Follicular
487
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
470
Lymphoma, Mantle-Cell
459
Lymphoma, Large B-Cell, Diffuse
444
Burkitt Lymphoma
432
Hodgkin Disease
431
Lymphoma, B-Cell, Marginal Zone
424
Multiple Myeloma
415
Lymphoma, Large-Cell, Immunoblastic
335
Leukemia, Myelomonocytic, Chronic
314
Congenital Abnormalities
287
Recurrence
279
Leukemia, Myeloid, Chronic-Phase
272
Myeloproliferative Disorders
260
Neoplasms
256
Blast Crisis
250
Waldenstrom Macroglobulinemia
232
Leukemia, Myeloid, Accelerated Phase
217
Lymphoma, T-Cell, Cutaneous
213
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
208
Mycosis Fungoides
183
Lymphoma, Large-Cell, Anaplastic
181
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Arthritis, Juvenile
×
Other hematologic neoplasm
×
Clear all
NCT00964210
2011-04-15
HPV
Murdoch Childrens Research Institute
Phase 3
Completed
240 enrolled